Potential progression biomarkers of diabetic kidney disease determined using comprehensive machine learning analysis of non-targeted metabolomics
Source check: Source checked. Not independent scientific confirmation.
Finding: Longitudinal diabetic-kidney-disease metabolomics analysis used explainable machine learning to identify candidate progression biomarkers; these remain candidates, not validated clinical markers. The longitudinal analysis identifies candidate biomarkers; it does not establish causal mechanisms or clinical validation.
Technology: Explainable machine-learning metabolomics analysis
Publication: Peer-reviewed paper · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.
- AI contribution
- Analyzes longitudinal metabolomics data to identify candidate biomarkers associated with diabetic-kidney-disease progression.
- Test and result
- Longitudinal diabetic-kidney-disease metabolomics analysis used explainable machine learning to identify candidate progression biomarkers; these remain candidates, not validated clinical markers.
- Limitation / still unknown
- The longitudinal analysis identifies candidate biomarkers; it does not establish causal mechanisms or clinical validation. The source does not establish benefits beyond the reported evaluation.
Evidence sources and annotation context
Evidence context (descriptions follow the cited sources; test type is a catalog classification):
Evidence sources: https://www.nature.com/articles/s41598-022-20638-1
Source checked · editorial details
The source page was checked against this entry. Independent confirmation is not assessed by this label.
Source type: other. Paper: not linked in this catalog; this does not mean no paper exists.
Review date: 22 Nov 2026. Review scope: Primary result-bearing material for the stated method, result and evaluation, with bibliographic version information..
No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.
Editorial assessment: Impact 2/5 · Validation 2/5 · Novelty 2/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.